Presented at the American Heart Association (AHA) 2025 Scientific Sessions, the new guidelines emphasize tighter systolic BP ...

Ochsner Health, in partnership with MD Anderson, has established multiple cancer centers throughout the state of Louisiana, ...

Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and ...

Papillary muscle scarring (papSCAR) as detected by dark blood delayed-enhancement cardiovascular magnetic resonance (CMR) was ...

Panelists discuss how aligning evolving payer policies with real-world oncology practice is key to sustaining timely and ...

AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...

Natera's integration into OncoEMR enhances workflow efficiency, simplifying the ordering process for precision medicine tests in oncology practices. The integration supports timely treatment decisions ...

Panelists discuss how removing LDL-C targets in 2013 shifted focus from outcomes to statin use, weakening control efforts.

Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...

Panelists discuss how national policy reforms are reshaping oncology care by balancing affordability efforts with the need to ...

Nurse practitioners play an essential role in diagnosing, treating, and supporting individuals living with Alzheimer disease.

Vallerie McLaughlin, MD, the Kim A. Eagle M.D. Endowed Professor of Cardiovascular Medicine and professor of internal medicine at the University of Michigan Medical School, highlighted the need for ...